Westpac Banking Corporation reported a 6% rise in net profit for the first quarter of 2026, underpinned by strong capital ratios and ongoing transformation initiatives. The bank’s strategic focus on customer service and operational efficiency signals a confident outlook amid evolving market conditions.

Cochlear Limited reported a modest 1% rise in sales but a 9% fall in underlying net profit for the half year ended December 2025, as the rollout of its innovative Nucleus Nexa System faced longer-than-expected regulatory and contract hurdles. The company anticipates a robust second half driven by broader product availability and service growth.

Cochlear Limited posted a modest 1% increase in sales revenue for the half year ending December 2025, while underlying net profit fell 9%, impacted by cloud computing costs and a slower-than-expected Nexa System rollout. The company maintains its dividend and outlines cautious FY26 guidance.